Edition:
United States

Critical Outcome Technologies Inc (COT.V)

COT.V on TSX Venture Exchange

0.33CAD
29 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.33
Open
$0.33
Day's High
$0.34
Day's Low
$0.33
Volume
74,100
Avg. Vol
117,054
52-wk High
$0.90
52-wk Low
$0.29

COT.V

Chart for COT.V

About

Critical Outcome Technologies Inc. (COTI) is a clinical-stage biopharmaceutical company. The Company is engaged in drug discovery and development. The Company uses machine learning to develop targeted therapies thereby managing the timeline and cost of getting new drug therapies to market. The Company's artificial intelligence... (more)
No analyst recommendations are available for COT.V.

Overall

Beta: 0.51
Market Cap(Mil.): $49.22
Shares Outstanding(Mil.): 149.16
Dividend: --
Yield (%): --

Financials

  COT.V Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -0.05 -- --
ROI: -305.71 -8.48 -5.42
ROE: -305.71 -11.31 -4.68

BRIEF-Critical Outcome Technologies appoints chief scientific officer

* Critical Outcome Technologies appoints experienced biotech leader as chief scientific officer Source text for Eikon: Further company coverage:

May 11 2017

BRIEF-Critical outcome technologies announces departure of chief scientific officer

* Critical outcome technologies announces departure of chief scientific officer Source text for Eikon: Further company coverage:

Feb 01 2017

More From Around the Web

Earnings vs. Estimates